Maldives bans Aciloc injection batch over quality issues
It is manufactured by Kadila Pharmaceutical Limited (Ahmedabad) of India.
Top Stories
-
MDP accuses govt of restricting opposition's role in parliament
-
Court halts eviction of Riveli over unpaid MVR 7.8 million rent
-
Minister Saeed survives no-confidence vote with support of 54 MPs
-
Councillor proposes visits to support people with disabilities
-
Minister calls for self-reliance in safeguarding independence
Maldives Food and Drug Authority (MFDA) on Tuesday banned the use of specific batches of imported injections due to quality issues.
According to the authority, quality issues have been found in batch number RP21311 of Aciloc (Ranitidine injections) imported and used in the Maldives.
The MFDA banned the import, sale and use of the batch number.
According to MFDA:
-
It is manufactured by Kadila Pharmaceutical Limited (Ahmedabad) of India
-
If the batch found to be causing the problem is located in any pharmacy or health care facility, it should be notified
-
Recently, cough syrups manufactured by an Indian pharmaceutical company were also banned in the country
Related
Related
31 students treated for food poisoning at Addu camp
MFDA bans falsified batch of cancer drug Opdivo found in Maldives
Importing medicines without permit to carry fines of MVR 10,000
